In the assessment of 12-month price targets, analysts unveil insights for 4D Molecular Therapeutics, presenting an average ...

RBC Capital analyst Lisa Walter reiterated a Buy rating on 4D Molecular Therapeutics (FDMT – Research Report) today and set a price target of $39.00. The company’s shares opened today at $6.09.

4D Molecular (FDMT) presented 52-week wet age-related macular degeneration Phase IIb results at this weekend’s Angiogenesis, Exudation, and Degeneration meeting, and while there was some ...

The 4 Nations Face-Off has exceeded expectations through the first two nights. Both games have been electric so far this ...

Copyright © 2025 Bleacher Report, Inc. A Warner Bros. Discovery Company. All Rights Reserved.

After hours: February 13 at 6:55:41 PM EST Loading Chart for FDMT ...

As we survey the upcoming free agency and draft processes, let’s make 25 predictions for what may be coming in the months ahead. Where will quarterback Sam Darnold land? What happens with the ...

Palantir has delivered remarkable returns in the past year and is trading at an expensive valuation, but there's room for more upside. The AI software-platform specialist is scratching the surface ...

ESPN NFL insider Adam Schefter made a bold prediction about how the Chicago Bears will begin their 2025 NFL season. ESPN NFL insider Adam Schefter made a bold prediction about how the Chicago ...

Capricorn: Here are you free predictions for the week, from February 09 to February 15 ...

We’ve got all the info and analysis you need to know ahead of the game, including the latest info on the how to catch the opening tip, recent team performance, player stats, and of course, our ...

Super Bowl LIX is almost here. The game will kick off at 6:30 p.m. ET in New Orleans at the Caesars Superdome. For the second time in three years, the Kansas City Chiefs will face the Philadelphia ...